US Equity
BOLD
— BOUNDLESS BIO, INC.Boundless Bio, Inc. is a clinical-stage biotechnology company developing therapeutics that target extrachromosomal DNA in cancer.
💰 Market cap: $55.74M📍 10955 Alexandria Way, Suite 100, SAN DIEGO, CA, 92121 US🏷️ Biotechnology & Medical Research💵 Previous close: $2.57🔢 9,512 credits left
Add Column
All
Trend
| Date ▾ | Close ▾ |
|---|---|
| 2026-07-24 | $2.57 |
| 2026-07-23 | $2.52 |
| 2026-07-22 | $2.52 |
| 2026-07-21 | $2.48 |
| 2026-07-20 | $2.44 |
| 2026-07-17 | $2.48 |
| 2026-07-16 | $2.49 |
| 2026-07-15 | $2.47 |
| 2026-07-14 | $2.46 |
| 2026-07-13 | $2.44 |
| 2026-07-10 | $2.41 |
| 2026-07-09 | $2.51 |
| 2026-07-08 | $2.45 |
| 2026-07-07 | $2.50 |
| 2026-07-06 | $2.50 |
| 2026-07-02 | $2.50 |
| 2026-07-01 | $2.48 |
| 2026-06-30 | $2.50 |
| 2026-06-29 | $2.45 |
| 2026-06-26 | $2.56 |
| 2026-06-25 | $2.51 |
| 2026-06-24 | $2.60 |
| 2026-06-23 | $2.60 |
| 2026-06-22 | $1.40 |
| 2026-06-18 | $1.43 |
| 2026-06-17 | $1.40 |
| 2026-06-16 | $1.41 |
| 2026-06-15 | $1.40 |
| 2026-06-12 | $1.41 |
| 2026-06-11 | $1.39 |
| 2026-06-10 | $1.38 |
| 2026-06-09 | $1.40 |
| 2026-06-08 | $1.43 |
| 2026-06-05 | $1.42 |
| 2026-06-04 | $1.47 |
| 2026-06-03 | $1.44 |
| 2026-06-02 | $1.43 |
| 2026-06-01 | $1.44 |
| 2026-05-29 | $1.45 |
| 2026-05-28 | $1.46 |
| 2026-05-27 | $1.47 |
| 2026-05-26 | $1.47 |
| 2026-05-22 | $1.44 |
| 2026-05-21 | $1.45 |
| 2026-05-20 | $1.42 |
| 2026-05-19 | $1.40 |
| 2026-05-18 | $1.42 |
| 2026-05-15 | $1.49 |
| 2026-05-14 | $1.55 |
| 2026-05-13 | $1.54 |
| 2026-05-12 | $1.50 |
| 2026-05-11 | $1.55 |
| 2026-05-08 | $1.44 |
| 2026-05-07 | $1.53 |
| 2026-05-06 | $1.58 |
| 2026-05-05 | $1.57 |
| 2026-05-04 | $1.57 |
| 2026-05-01 | $1.57 |
| 2026-04-30 | $1.46 |
| 2026-04-29 | $1.45 |
| 2026-04-28 | $1.44 |